Navigation Links
Tracking prions
Date:6/17/2008

This release is available in German.

Infectious proteins known as prions have been identified as the cause of "mad cow" disease (BSE). The culprits are "incorrectly folded" proteins that can "infect" healthy proteins. The molecular bases for such prion diseases are not yet fully understood. Why are some proteins infectious while others are not? A team headed by Beat Meier (ETH Zurich, Switzerland) and Raimon Sabat (University of Bordeaux, France) has examined two different forms of a prion-forming protein domain by means of NMR spectroscopy. In the journal Angewandte Chemie, the researchers report that the infectious and non-infectious forms differ markedly in their molecular structure.

The word prion is derived from the term Proteinaceous Infectious Particle. These are proteins that can fold in different ways. Pathogenic prions are dangerous because they can convert physiological, non-pathogenic molecules into the diseased form. Often, prions largely consist of -sheet structures. These are accordion-like folded protein ribbons that can easily aggregate into thread-like structures (amyloid fibrils).

The research team took on the prion-forming domain of the fungal protein HET-s. At a pH value of 7under physiological conditionsthis domain forms infectious fibrils. In acidic solution, at pH 3, it also forms fibrils, but these are not infectious.

By using nuclear magnetic resonance spectroscopy (NMR), the team was able to get a closer look at this protein. NMR allows for the evaluation of interactions of the nuclear spins of specific atomic nuclei with each other and their chemical surroundings, which gives information about the structure and dynamics of molecules and molecular fragments.

Here's what the researchers found: The spectra of the pH 7 and pH 3 versions of the prion differ significantly. Both are mainly arranged in the rigi
'/>"/>

Contact: Beat Meier
beat.meier@nmr.phys.chem.ethz.ch
41-446-324-401
Wiley-Blackwell
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Tracking feline memories on the move
2. Louisiana Tech researchers investigate tracking, sensors to assist Air Force
3. NIH recognizes Clemson nanotechnology for molecule tracking
4. GestureTek/Imagination Launch AirPoint, Worlds First Hand-Tracking Unit, for Shell Group.
5. Tracking stroke
6. Tracking influenzas every movement
7. Prions and retroviruses -- an unholy alliance?
8. Prions show their good side

Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Tracking prions
Tracking prions
(Date:11/4/2009)...ember 4, 2009 Childhood obesity in the United Sta...an one fourth of advertising on daytime and prime ... continuing questions about the role television pl...ssue of the Journal of Nutrition Education and Be...ldren might be a large contributor to the problem....
(Date:11/4/2009)... Oct. 20 Quest Diagnosti... provider of diagnostic testing, information and s...d September 30, 2009, income from continuing opera...hare, from $160 million, or $0.81 per diluted shar...uarter results were reduced by a $0.03 per share c...
(Date:11/4/2009)...t. 26 BIO-key Internatio...finger-based biometric identification software is ... the AABB TXPO conference being held at the New Or...IO-key will provide hands-on product demonstration...y in booth #424. Also, at 5 PM on Monday, October ...
Breaking Biology News(10 mins):TV bombards children with commercials for high-fat and high-sugar foods 2TV bombards children with commercials for high-fat and high-sugar foods 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 2Quest Diagnostics Reports Strong Performance in Third Quarter 2009 3Quest Diagnostics Reports Strong Performance in Third Quarter 2009 4Quest Diagnostics Reports Strong Performance in Third Quarter 2009 5Quest Diagnostics Reports Strong Performance in Third Quarter 2009 6Quest Diagnostics Reports Strong Performance in Third Quarter 2009 7Quest Diagnostics Reports Strong Performance in Third Quarter 2009 8Quest Diagnostics Reports Strong Performance in Third Quarter 2009 9Quest Diagnostics Reports Strong Performance in Third Quarter 2009 10Quest Diagnostics Reports Strong Performance in Third Quarter 2009 11Quest Diagnostics Reports Strong Performance in Third Quarter 2009 12Quest Diagnostics Reports Strong Performance in Third Quarter 2009 13Quest Diagnostics Reports Strong Performance in Third Quarter 2009 14Quest Diagnostics Reports Strong Performance in Third Quarter 2009 15Quest Diagnostics Reports Strong Performance in Third Quarter 2009 16Quest Diagnostics Reports Strong Performance in Third Quarter 2009 17BIO-key(R) International Exhibiting at AABB TXPO 2RMACT Celebrates Seven Years of Growing Families 57136 1RMACT Celebrates Seven Years of Growing Families 57136 2RMACT Celebrates Seven Years of Growing Families 57136 3RMACT Celebrates Seven Years of Growing Families 57136 4Treating bone loss in breast cancer survivors 9926 1Treating bone loss in breast cancer survivors 9926 2Ecosystem researchers to hold science briefing for policymakers 9925 1
...n in yeast, worms, and flies keeps blood sugar und...ust Cell Metabolism. The findings suggest therapeu... of metabolic disorders, such as type 2 diabetes, ...aid. , The team found that mice with an excess of ...proved glucose tolerance and enhanced insulin secr...
...ired infections can persist for days and even week...ttings, including bed linens, computer keyboard co...h presented today at the 105th General Meeting of ...in-resistant Staphylococcus aureus (MRSA) is a maj...ited States. Staphylococcal infections can cause c...
...,s motor nerve cells grow along proper paths durin... inhibiting spinal-cord neurons from regenerating ...al Center have found. In cultured cells, the resea...ce that normally insulates and stabilizes long ner...the ability of nerve cells to grow through myelin ...
Other Biology News:Sea Ice May Be on Increase in the Antarctic 2Researchers find molecule that inhibits regrowth of spinal nerve cells 2Researchers find molecule that inhibits regrowth of spinal nerve cells 3
(Date:11/6/2009)...EO, Calif., Nov. 6 ,...transfer of Qutenza(TM) E.U. Marketing Authorizati...nt progress in commercial readiness activities Ex... Director, Marketing; and Director, Commercial Ope... director and Audit Committee chairman , Up...
(Date:11/6/2009)..., Nov. 6 /PRNewswire-FirstCall/ - Oncolytics Biote...e "Company") today announced updated results from ...ients with sarcomas metastatic to the lung in a po...ssue Oncology Society Meeting held in Miami Beach,...sentation, entitled "A Phase II Study of Intraveno...
(Date:11/6/2009)... The agenda for Arrowhead’s 2010...ich is set to take place on February 22-24, 2010 i...day conference we will highlight key issues in for...share their experiences. , ...agenda for Arrowhead’s 2010 Personalized Me...
(Date:11/5/2009)...SBURG, Md., Nov. 5 GenVe...cial results for the third quarter ended September...ion ($0.04 per share) for the three months ended S...illion ($0.08 per share) in the comparable quarter...2009, GenVec,s net loss was $14.1 million ($0.15 p...
Breaking Biology Technology:NeurogesX Reports Third Quarter 2009 Results 2NeurogesX Reports Third Quarter 2009 Results 3NeurogesX Reports Third Quarter 2009 Results 4NeurogesX Reports Third Quarter 2009 Results 5NeurogesX Reports Third Quarter 2009 Results 6NeurogesX Reports Third Quarter 2009 Results 7NeurogesX Reports Third Quarter 2009 Results 8NeurogesX Reports Third Quarter 2009 Results 9NeurogesX Reports Third Quarter 2009 Results 10Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 2Leaders in Biopharma and Molecular Diagnostics to Discuss Key Issues and Opportunities in Forming Partnerships at 2010 Personalized Medicine Partnerships Conference 3GenVec Reports Third Quarter 2009 Financial Results 2GenVec Reports Third Quarter 2009 Financial Results 3GenVec Reports Third Quarter 2009 Financial Results 4GenVec Reports Third Quarter 2009 Financial Results 5GenVec Reports Third Quarter 2009 Financial Results 6
... Biotech Ltd. (Amex:,SVA), a leading provider of v...h of Anflu(R), a seasonal influenza vaccine, for 2... Sinovac, Anflu(R) is the only split influenza,vac...vac is undertaking the,sales and marketing program...the adult dosage form of Anflu(R)., Utilizing the...
...ber 11 at 11:00 AM ET, WAYNE, Pa., Sept. 10 Enco...multinational clinical research organization,(CRO)...of the world,s,leading pharmaceutical and biotechn...nted Dr. David Ginsberg, Chief Executive Officer o...sition from Dr. Kai Lindevall, who,was named to th...
...ber of US clinics, CHICAGO, IL, Sept. 10 /PRNewsw...st commercially available bionic hand, today revea...8 National Assembly of the American,Orthotic and P...ovember 3,2008, the company,s RACE Team and Partne...rt to the growing number of prosthetics clinics th...
Other Biology Technology:Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season 2Sinovac Launches Seasonal Influenza Vaccine Anflu(R) for 2008-2009 Flu Season 3Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 2Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 3Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 4Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 5Encorium Appoints David Ginsberg President and Chief Executive Officer, Announces Changes to the Board of Directors 6Touch Bionics unveils innovative partner and reimbursement programs at AOPA 2Touch Bionics unveils innovative partner and reimbursement programs at AOPA 3
Rabbit Anti-D4-GDI Polyclonal Antibody, Unconjugated from Assay Designs/Stressgen Bioreagents
Rabbit Anti-MAL Polyclonal Antibody, Unconjugated from Abcam
Rabbit Anti-Human ADAM-12 (Meltrin alpha), amino terminal region Antibody, Unconjugated from CEDARLANE Laboratories Limited
Rabbit Anti-FLIP Polyclonal Antibody, Unconjugated from Abcam
Biology Products: